Redefining the future of pharmaceutical production with cutting-edge digital technology, collaborative expertise, and more sustainable manufacturing practices.

Address and directions for CPI's Medicines Manufacturing Innovation Centre at Paisley, Glasgow..

We have today opened our Medicines Manufacturing Innovation Centre facility in Glasgow City Region, Scotland. The £ 88 million Centre is bringing world-leading science and technology expertise under one roof to help accelerate state-of-the-art solutions to some of the biggest challenges in medicines development and manufacturing.

药品制造创新中心 (MMIC)是CPI（过程创新中心）、斯特拉斯克莱德大学、英国研究与创新、苏格兰企业和创始行业合作伙伴、阿斯利康和葛兰素史克的一个合作项目。

2021年11月3日 · The Centre for Process Innovation (CPI), the University of Strathclyde, Scottish Enterprise, Innovate UK, AstraZeneca and GlaxoSmithKline (GSK) have partnered to open the Medicines Manufacturing Innovation Centre (MMIC) in Renfrewshire, Scotland.

2022年12月1日 · The Medicines Manufacturing Innovation Centre has six founding partners: pharmaceutical giants, AstraZeneca and GSK; technology innovation catalyst, CPI; strategic research partner, the University of Strathclyde; and two government agencies, UK Research and Innovation (UKRI) and Scottish Enterprise.

2021年8月23日 · Located in Renfrewshire, at the heart of the emerging Advanced Manufacturing Innovation District Scotland (AMIDS), the £35 million Medicines Manufacturing Innovation Centre is set to develop next-generation pharmaceutical manufacturing processes to drive forward innovation in the medicines supply chain.

An innovative research, development and manufacturing facility, the new Medicines Manufacturing Innovation Centre (MMIC) in Renfrewshire will support the UK’s pharmaceutical and fine chemicals industries in accelerating a new generation of manufacturing processes.

2023年1月15日 · Established in 2018, The Medicines Manufacturing Innovation Centre (MMIC) is a collaboration between CPI, University of Strathclyde, UK Research & Innovation, Scottish Enterprise and founding industry partners AstraZeneca and GSK, dedicated to developing advanced solutions for pharmaceutical manufacturing.

Located in Renfrewshire, at the heart of the emerging Advanced Manufacturing Innovation District Scotland (AMIDS), the £ 35 million facility is set to develop next-generation pharmaceutical manufacturing processes to drive forward innovation in the medicines supply chain.